Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/dsu.12331 | DOI Listing |
Dermatol Online J
October 2024
Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA Division of Dermatologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
The call for robust randomized clinical trials (RCTs) comparing Mohs micrographic surgery (MMS) with wide local excision for treatment of melanoma has stymied the development of guidelines for MMS despite growing evidence of benefit. This commentary explores the controversy by detailing opposing arguments, reviewing the relevant evidence supporting the use of MMS for early-stage melanoma, and discussing the role that RCTs may play in development of national guidelines for surgical treatment options for melanoma. Randomized clinical trials are considered the gold standard of clinical research, but there are no such trials currently to support MMS for melanoma.
View Article and Find Full Text PDFDermatol Surg
November 2024
Epiphany Dermatology, Dallas, Texas.
Br J Dermatol
October 2024
Division of Dermatologic Surgery, Mayo Clinic, Rochester, MN, USA.
BMC Surg
October 2024
Department of Research and Education, Oli Health Magazine Organization, Kigali, Rwanda.
Dermatol Surg
September 2024
Division of Dermatologic Surgery, Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!